NMT Medical, Inc. (NASDAQ: NMTI), a leader in the emerging field of structural heart repair, is focused on designing, developing, manufacturing and marketing proprietary implant technologies that allow interventional cardiologists to treat certain structural heart disease through minimally invasive, catheter-based procedures. By working with qualified physicians, the company has provided minimally invasive treatment for an array of cardiac defects for more than two decades. For further information, visit the Company’s web site at www.nmtmedical.com.
- 17 years ago
QualityStocks
NMT Medical, Inc. (NASDAQ: NMTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…